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Abstract 
Background: The aim of this study was to evaluate the biochemical and immunological characteristics of saliva from 
diabetic patients compared to non‑diabetic adults.
Methods: Eighty‑eight diabetic adults and 39 non‑diabetic adults (control) were included in the study. Glucose, urea, 
calcium, total protein and amylase were determined by a colorimetric method. The levels of secretory IgA and the IgA 
anti‑Streptococcus mutans and anti‑insulin IgA antibodies were measured by enzyme‑linked immunosorbent assay 
(ELISA). Caries status was evaluated using the DMFT index.
Results: Glucose, urea, calcium, anti‑S. mutans IgA, total IgA, and anti‑insulin IgA were significantly higher in diabetic 
patients, whereas total protein and amylase levels were lower in these patients. There was no positive correlation 
between blood and salivary glucose levels in either group. Diabetic patients had a higher DMFT index.
Conclusions: The present study showed for the first time that IgA levels in diabetic patients’saliva, shows correlation 
with systemic biochemical parameters. Thus the saliva is an useful tool to follow the systemic health status in these 
patients.
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Background
Diabetes mellitus is a public health problem since, in 
addition to important social repercussions. It is a chronic 
disease that affects a growing number of individuals 
from different countries which are at different stages of 
economic and social development [1]. Diabetes is classi-
fied into four clinical types: type 1 diabetes which results 
from β-cell destruction and usually leads to absolute 
insulin deficiency; type 2 diabetes which results from 
a progressive insulin secretory defect associated with 
insulin resistance; other specific types of diabetes due to 
other causes, and gestational diabetes mellitus [2].
Systemic diseases such as diabetes compromise salivary 
gland function and consequently influence the quan-
tity and quality of saliva produced. Alterations in the 
chemical components and physical properties of saliva 
can serve as diagnostic parameters and saliva testing 
may therefore be added to the arsenal of complemen-
tary tests [3]. Saliva has several advantages over serum, 
including its simple and noninvasive collection and easy 
storage, transport and handling [4]. The wide variety of 
components found in saliva permits its use for diagnosis, 
prognosis and monitoring of human diseases [5], such as 
hereditary or congenital diseases [6], autoimmune dis-
eases, cardiovascular diseases, infections [7], cancer [8], 
diabetes [9], caries [10], and periodontal disease [11], 
among others.
Differences in saliva production and composition have 
been observed previously between diabetic and non-dia-
betic subjects [12, 13]. Some authors have shown variable 
correlation rates between serological and saliva data [9, 
12, 14]. However, despite this apparent controversial the 
saliva seems to be important and useful to evaluate physi-
ologic alterations.
The aim of the present study was to evaluate the bio-
chemical and immunological profile of saliva in diabetic 
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patients, considering the total production of IgA, and the 
concentration specific IgA anti-insulin and anti-Strep-
tococcus mutans, as additional biomarkers in saliva to 




The sample size was calculated based on the prevalence 
of diabetes in Maranhão (MS Hiperdia [15]), with a confi-
dence interval of 95 %. Data were collected systematically 
during 6 month. The sample consisted of 142 subjects (93 
diabetics and 49 controls).
The population was divided into two groups age-sex 
matched: DIABETIC and NON DIABETIC. The diabetic 
group comprises patients with diabetes type I and Type 
II, since there are no statistic differences among them, 
with a previous diagnosis of more than 4 years.
This study used a convenience sample based on the fol-
lowing inclusion criteria: age older than 18 years, a pre-
vious diagnosis of diabetes mellitus, and participation 
in the Diabetes Program of Presidente Dutra University 
Hospital, São Luís, Maranhão, Brazil. Only 88 diabetic 
patients, who met the inclusion criteria, had sufficient 
salivary flow for analysis and effectively agreed to par-
ticipate in the study. The following criteria were used for 
inclusion in the control group: age older than 18  years, 
no systemic disease or diabetes, and no history of medi-
cation use. Only 39 non-diabetic adults, who met the 
inclusion criteria, effectively participated in the study. 
Sociodemographic data were obtained by semi-struc-
tured interview.
All subjects received information regarding the objec-
tive and procedures of the study and only participated 
in the data collection after signing a free informed con-
sent form. The study protocol was approved by the Ethics 
Committee of Universidade Federal do Maranhão (Proto-
col No. 33104-149).
Collection of saliva samples
Unstimulated whole saliva was collected, in fasting, 
from diabetic and non-diabetic subjects over a period 
of 5 min. After rinsing their mouth with filtered water, 
the subjects were asked to spit saliva into a sterile 
flask. The flasks were sealed immediately after sample 
collection and refrigerated at 4  °C before transport to 
the laboratory. The saliva samples were centrifuged 
(10,000 rpm, 10 min) to reduce salivary debris and vis-
cosity. Glucose and total protein concentrations were 
determined immediately after centrifugation. The other 
parameters were evaluated later in a supernatant stored 
at −20 °C.
Biochemical analysis
Glucose, total protein, urea, calcium and amylase con-
centrations were determined by a colorimetric method. 
The analyses were performed using automated proce-
dures on an Architect C8000 apparatus (Abbott®) for 
glucose, amylase, total protein and calcium. Individual 
samples were tested in triplicate.
Determination of IgA levels
Salivary total IgA, anti-S. mutans IgA and anti-insu-
lin IgA antibodies were determined by enzyme-linked 
immunosorbent assay (ELISA) as described previously 
[11]. Briefly, anti-human IgA (Sigma, St. Louis, USA) 
was diluted to a concentration of 50 µg/mL in carbonate-
bicarbonate buffer (pH 9.6) and adsorbed onto ELISA 
strips in flat-bottom wells (NUNC, Roskilde, Denmark), 
followed by overnight incubation at 4 °C. The wells were 
then washed five times with 0.15 M phosphate-buffered 
saline (PBS; pH 7.2) containing 0.05  % Tween 20 (Pro-
mega, Madison, USA; PBS-T) and incubated in PBS 
containing 1  % bovine serum albumin (Sigma) for 1  h 
at 37  °C. The wells were washed five times and 100  µL 
of tenfold dilutions (1:100 to 1:1000) of saliva samples 
in PBS was added. After 30  min at 37  °C and further 
washing, 100 µL alkaline phosphatase-labeled goat anti-
human IgA (Sigma; diluted 1:1000 in PBS-T) was added 
to the wells and the strips were incubated for 2 h at 37 °C. 
The strips were then washed five times with PBS-T. The 
color was developed by adding 100  µL of a solution of 
ρ-nitrophenylphosphate (Sigma) and incubating the 
strips for 30 min in the dark. The reaction was stopped 
with 1  N NaOH (Sigma) and the optical density was 
measured at a wavelength of 405 nm.
Clinical examination
The caries status of the patients was evaluated using the 
DMFT (decayed, missing and filled permanent teeth) 
index and was performed by a single examiner. Data on 
oral hygiene, access to dental care, and salivary flow were 
also collected.
Statistical analysis
Quantitative variables were compared between the two 
groups by the Student t test. The correlation between 
diabetic and non-diabetic patients was evaluated using 
Pearson’s linear correlation coefficient. A receiver oper-
ating characteristic (ROC) curve was constructed for the 
diagnostic test. This analysis considered glucose, total 
protein, urea, anti-insulin Ig, and amylase concentra-
tions. The test was defined as positive when alterations 
in at least four parameters were observed. The sensitivity 
of the test was 88 %, specificity was 90 %, and diagnostic 
Page 3 of 7Lima‑Aragão et al. BMC Res Notes  (2016) 9:103 
accuracy was 89 %. Categorical variables were compared 
by Fisher’s exact test. The level of significance for rejec-
tion of the null hypothesis was set at p ≤ 0.05 in all tests. 
All analyses were performed using the GraphPad Prism 
5.0 program.
Results
The control group consisted of 39 clinically healthy 
subjects with a mean (±SD) age of 23 ± 6 years (range: 
19–50  years). The mean (±SD) age of the diabetic 
patients was 52 ± 18 years (range: 18–84 years).
Fifty-seven of the 88 diabetic patients were females and 
31 were males, and 59 were using insulin. The time since 
diagnosis of diabetes was 11 ± 8 years. Blood glucose lev-
els were 261 ± 131 mg/dL. The data obtained for diabetic 
patients were compared to a control (non-diabetic) group 
of 39 subjects, including 22 females and 17 males. The 
mean (±SD) blood glucose levels were 92 ± 9 mg/dL in 
this group.
Table 1 shows the salivary biochemical parameters and 
Fig. 1 illustrates the immunological parameters. Glucose, 
urea, calcium, anti-S.mutans IgA, total IgA and anti-
insulin IgA were significantly higher in diabetic patients 
(p  <  0.05). On the other hand, total protein and amyl-
ase concentrations were significantly lower in diabetic 
patients (p < 0.05).
No positive correlation was observed between blood 
and salivary glucose levels in either group, although glu-
cose levels were higher in diabetic patients than in the 
control group (Table 1). A negative correlation was found 
between salivary glucose concentration and anti-insulin 
IgA.
The diabetic patients were divided into two subgroups 
according to the use or not of insulin. The results showed 
no significant differences between diabetes I or diabetes 
II patients. For this reason, the salivary data were evalu-
ated together as diabetic patients (Table 2).
A ROC curve was constructed to validate the salivary 
parameters that could be used for diagnostic testing. 
Glucose, total protein, urea, anti-insulin IgA, amylase 
and calcium concentration were included in the analysis. 
Only calcium was excluded after ROC analysis since it 
exhibited an area of 0.5, i.e., this parameter was not sta-
tistically significant (Table 3).
Table 1 Salivary parameters of  diabetic and  non-diabetic 
patients
a Saliva samples obtained from 39 non‑diabetic (control) subjects and 88 
diabetic patients of both genders were evaluated
b Results are reported as the mean ± standard deviation (X ± SD)
Parameter Controla Diabetica p value
Glucose (mg/dL) 3 ± 0.03b 11 ± 2 0.01
Urea (mg/dL) 17 ± 1 27 ± 1 0.0001
Calcium (mg/dL) 2 ± 0.1 2 ± 0.1 0.0004
Total protein (mg/dL) 2 ± 0.1 0.3 ± 0.03 0.0001
Amylase (AU/dL) 37 ± 0.4 37 ± 0.1 0.008
Fig. 1 Salivary concentration of total IgA, anti‑mutans (Streptococ-
cus mutans) IgA and anti‑insulin IgA in diabetic patients and healthy 
controls. The results are reported as the mean ± standard deviation 
(X ± SD) of 88 diabetic patients and 39 controls. (*) Significant when 
p < 0.05 compared to the control group
Table 2 Salivary composition of  diabetic patients who 
used insulin or not
a Saliva samples obtained from 88 diabetic patients of both genders were 
evaluated
b Results are reported as the mean ± standard deviation (X ± SD)
Parameter Use of insulin p value
Yes No
Glucose 12 ± 3b 9 ± 3b 0.51
Urea 28 ± 1 25 ± 1 0.06
Calcium 2 ± 0.1 2 ± 0.2 0.41
Amylase 0.3 ± 0.1 0.2 ± 0.1 0.56
Total protein 37 ± 1 37 ± 1 0.57
Anti‑mutans IgA 21 ± 1 20 ± 2 0.59
Total IgA 35 ± 1 36 ± 1 0.61
Anti‑insulin IgA 28 ± 2 27 ± 2 0.51
Table 3 Area under  the ROC curve obtained for  salivary 
parameters of diabetic patients
a Saliva samples obtained from 88 diabetic patients of both genders were 
evaluated





Glucose 0.99 0.01 <0.0001
Total protein 0.98 0.02 <0.0001
Amylase 0.95 0.02 <0.0001
Anti‑insulin IgA 0.84 0.04 <0.0001
Urea 0.81 0.05 <0.0001
Calcium 0.55 0.06 0.4274
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Clinical examination showed a high DMFT index in 
diabetic patients (Table 4). Furthermore, compared to the 
control group, these patients had poor oral hygiene and 
less access to dental care and exhibited xerostomia signs 
such dry mouth (Table 5).
Discussion
Whole saliva is a mixture of salivary gland secretions con-
taining substances derived from gingival crevicular fluid, 
desquamated epithelial cells, food rests, microorganisms, 
and products derived from microbial metabolism [16]. 
Since stimulation affects both the production of saliva 
and the concentration of some of its components [3, 17], 
in the present study unstimulated whole saliva was used 
to evaluate oral alterations associated with diabetes in 
adult patients.
A significant increase in the salivary concentration 
of glucose, calcium and urea was observed in diabetic 
patients. Similar results of calcium concentration have 
been reported previously [18]. Furthermore, the increases 
were similar to those reported by other investigators that 
evaluated biochemical parameters in the saliva of dia-
betic patients [12]. Changes in salivary composition have 
been suggested to affect the development, symptoms and 
severity of many oral diseases, particularly in diabetic 
patients [9].
No correlation between salivary and blood glucose 
levels was observed in diabetic patients despite higher 
salivary glucose concentration in this group. Salivary and 
blood levels of glucose may be considered independent 
variables as previously described for adults [12–14] and 
children with diabetes [19]. According to Jurysta et  al. 
[13], salivary glucose concentration measured either 
in unstimulated or stimulated saliva is always higher in 
diabetic patients than in control subjects, and this high 
concentration exerts potentially unfavorable effects on 
the oral health of these patients. These results agree with 
the present findings and confirm the weak association 
between blood glucose levels and glucose concentration 
or excretion in saliva, at least in individual cases [14].
Total amylase and protein were significantly lower in 
diabetic patients. Amylase was evaluated as a marker of 
metabolic and hormonal changes in salivary gland prod-
ucts. Yavuzyilmaz et al. [20] also reported lower levels of 
amylase in diabetic patients. In contrast, salivary total 
protein concentration differed from that reported in 
studies evaluating this parameter after freezing and stor-
age of the sample [21]. This difference might be explained 
by the fact that in the present study the assay was per-
formed immediately after collection and centrifugation 
of the saliva samples to prevent endogenous proteolytic 
activity [4].
Evaluation of immunological changes in saliva showed 
a higher total IgA antibody concentration in diabetic 
patients. These findings are probably associated with the 
elevated levels of specific anti-S. mutans and anti-insu-
lin antibody levels also observed in these patients. The 
determination of changes in whole saliva composition 
may be used to diagnose possible variations and defective 
host immune responses, including the secretion of s-IgA 
[22]. Similar results have been reported in other studies 
evaluating the salivary production of IgA antibodies in 
diabetic patients [20, 23].
According to Batista et  al. [23], S. mutans counts are 
usually higher in diabetic patients. Although the degree 
of infection of the patients was not quantified in this 
study, elevated anti-S. mutans antibody titers might be 
related to an increased bioavailabilityof bacterial anti-
gens. The local response of specific antibodies to cer-
tain plaque bacteria such as S. mutans may identify sites 
with a potential risk of developing caries and other oral 
Table 4 Index of  decayed, missing and  filled permanent 
teeth (DMFT) in diabetic patients
a Results are reported as the mean ± standard error of the mean
b DMFT decayed, missing, filled permanent teeth
Index Diabetic (n = 88) Control (n = 39) p value
D 4 ± 0.4a 1 ± 0.2 <0.001
M 16 ± 1 0.5 ± 0.2 <0.001
F 1 ± 0.2 3 ± 0.4 <0.001
DMFTb 20 ± 1 5 ± 0.5 <0.001
Table 5 Oral hygiene, access to dental care and dry mouth 
sensation in diabetic patients and controls
a f (%), frequency expressed as percentage
b Fisher’s exact test
Diabetic f (%)a Control f (%)a p valueb
Number of tooth brushing
 1–2 52 10 <0.0001
 3–4 48 90
 Total 100 100
Use of dental floss
 Yes 22 67 <0.0001
 No 78 33
 Total 100 100
Last dental visit
 1 year 23 61 <0.0001
 2–3 years 77 38
 Total 100 100
Dry mouth sensation
 Yes 63 5 <0.0001
 No 37 95
 Total 100 100
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diseases even before onset of the first clinical signs [24]. 
Streptococcusmutans is a Gram-positive bacterium that is 
potentially aggressive to various tissues. Elevated anti-S. 
mutans IgA concentrations may indicate that the patients 
are systematically exposed to this microorganism, as well 
as a higher caries risk [25], especially if we consider the 
poor oral hygiene and less access to dental care showed 
in the present study (Table 5).
In the present study high levels of anti-insulin IgA anti-
bodies were detected in saliva from diabetic patients and 
this result may explain the elevation of glucose levels 
observed in diabetic patients. The diabetes hyperglyce-
mia Insulin is known to have a regulatory role on glu-
cose levels and the anti-insulin antibodies are frequently 
responsible to block the insulin ligation to the respective 
receptor, increasing the biodisponibility of this hormone 
and decreasing its action [26–28], resulting from defects 
in insulin secretion, insulin action, or both [2], observed 
in diabetes.
There is no previous report about anti-insulin anti-
bodies in saliva from diabetic patients in association 
with other salivary profile. For this reason the results 
altogether may highlight information about the salivary 
biomarkers in diabetic patients, since the detection of 
anti-insulin antibodies are frequently associated to insu-
lin antibody-induced insulin resistance and can be used 
as diagnostic and prognostic markers to diabetes, but 
also to other autoimmune diseases [26, 27].
According Eisenbarth (2003) [28], specific patterns of 
autoantibody expression may predict risk and progres-
sion to diabetes ranging from 20  % to >90  %, mainly in 
diabetes type I. We propose a detection of IgA anti-insu-
lin in saliva as useful tool to predict diabetes risk early, 
as well as, an important result to monitoring the pro-
gression of disease in diabetic patients, with the same 
accuracy as that obtained for serum anti-insulin antibod-
ies and with less discomfort to the patients during fluid 
collection.
Considering a large number of patients were using 
injectable insulin, we investigated whether this treatment 
alters the variables analyzed. No significant differences in 
salivary biochemical or immunological parameters were 
observed between non-insulin-dependent and insulin-
dependent diabetic patients. Similar findings have been 
reported by Jurysta et al. [13] and Yavuzyilmaz et al. [20] 
who also compared saliva of insulin-dependent and non-
insulin-dependent diabetic patients.
Biochemical and immunological alterations in the 
saliva of diabetic patients have been described and sali-
vary changes may serve as a complementary parameter 
for the diagnosis of diabetes mellitus [3]. In the present 
study, the clinical performance of an individual test was 
demonstrated by the ROC curve after the variables had 
been combined and were validated for diagnostic use. 
The greater the capacity of a test to discriminate between 
diabetic and non-diabetic subjects, the closer is the curve 
to the left corner of the graph, with an area under the 
curve close to 1 [29]. The sequence of individual varia-
bles that best discriminate diabetic patients was glucose 
(area of 0.99), total protein (area of 0.98), amylase (area 
of 0.95), anti-insulin IgA (area of 0.83), and urea (area 
of 0.80). The accuracy of the diagnostic test combining 
these parameters was 89 %. A similar accuracy (90 %) has 
been reported by Lopez et al. [19] who used saliva for the 
diagnosis of diabetes in children considering calcium, 
urea, total sugars, glucose and total protein concentra-
tion as done in the present study for adult patients.
The association of dental caries with diabetes is less 
clear. In this study, diabetic patients had a higher DMFT 
index than control subjects. The average number of teeth 
lost was 16 and the average number of decayed teeth was 
3.7, which were responsible for the high DMFT index in 
these patients. The dry mouth sensation and increased 
salivary glucose levels observed here may alter the effec-
tiveness of salivary protection against caries [10]. Other 
factors such as poor oral hygiene and deficient regular 
care of these patients can aggravate pre-existing diseases. 
Data from clinical evaluation may explaining the high 
level of IgA anti-S.mutans, as low salivary flow, and high 
DMFT index are frequently associated to an increase in 
bacterial counts and the risk of infection among diabetic 
patients.
Its important to emphasizes the age differences 
between the control group (23 ± 6, range: 19–50 years) 
and diabetic patients (52  ±  18), as well the range intra 
group (range: 18–84 years), due to the inclusion criteria 
What can also influence the differences found between 
the two groups.
Diabetic patients with reduced salivary flow have an 
increased risk of enamel hypomineralization and car-
ies formation [30]. A decrease in salivary flow can cause 
oral alterations such as an increase in the concentration 
of mucin and glucose. Proliferation of pathogenic micro-
organisms may also occur. The consequences of chronic 
hyperglycemia include tongue alterations, periodon-
tal disease, tooth demineralization, and an increased 
infection risk [31]. The early detection and treatment of 
hyperglycemia and hyposalivation may provide a useful 
strategy to prevent the dental complications of diabetes 
and to promote oral health in this population [32].
Salivary composition in diabetes type 1 and 2 can be 
correlated to an increased risk of periodontal disease 
[33, 34]. Carda et  al. [16], evaluating type 2 diabetic 
patients, found symptoms of periodontal disease asso-
ciated with tooth decay and tooth loss in all patients. 
Jones et  al. [35] demonstrated an increased caries risk 
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in 457 patients with diabetes mellitus. Their study 
included patients with type 1 and type 2 diabetes, simi-
lar to the present study.
There was a positive correlation between DMFT and 
total IgA and a negative correlation between DMFT and 
tooth brushing in diabetic patients. Similar results have 
been reported by Smith and Taubman [36] for adult 
patients. In the group with caries, the authors observed a 
significant positive correlation between plaque index and 
specific IgA.
The diagnostic value of saliva has been demonstrated 
in a series of studies showing the accuracy and specific-
ity of this body fluid for the diagnosis of diseases [3–5, 
7–9, 12, 13, 17, 19, 20, 37]. The ease of collection of 
saliva samples and the lower risk of contamination of 
healthcare workers during sample handling are impor-
tant advantages that support the use of this fluid as a 
diagnostic tool. Furthermore, studies comparing the 
results of saliva analysis with other reliable scientific 
methods, such as blood measurements, have demon-
strated that the method is reliable and its application is 
therefore valid.
There is no previous report about the detection of anti-
insulin in saliva of diabetic patients and its relation to sev-
eral biochemical parameters. The present study was the 
first to demonstrate that a combination of immunologi-
cal and biochemical parameters as useful data to moni-
tor diabetic patients, since significant differences were 
observed in the saliva composition of diabetic patients, 
The alterations detected indicating a strong relationship 
between our findings and the systemic health status of 
the patient. Moreover, some salivary parameters were 
found to be useful to classify an adult as diabetic. This 
difference in salivary composition thus suggests the use 
of saliva as an alternative fluid to monitor patients with 
diabetes mellitus, considering the increase of diabetes 
not only in Brazil but also in other countries and the pos-
sibility to find new forms of diagnosis to design preven-
tion strategies.
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